PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
23-Dec-2024 Ensysce Biosciences Regains Full Compliance with Nasdaq AccessWire
23-Dec-2024 Telomir Pharmaceuticals Confirms Copper Binding Capabilities of Telomir-1 and Expands Pipeline Into Wilson's Disease AccessWire
23-Dec-2024 NanoViricides is in a Great Position to Fight Potential Bird Flu Pandemic with a Drug that the Mercurial H5N1 Influenza A Virus is Unlikely to Escape AccessWire
23-Dec-2024 Zomedica Launches Two New Quantitative Assays on the TRUFORMA(R) Platform: Canine NT-proBNP and Progesterone AccessWire
23-Dec-2024 Siegfried once again confirmed in the Dow Jones Sustainability Index Europe Siegfried AG
20-Dec-2024 Quantum Biopharma Announces Closing of Second Tranche AccessWire
20-Dec-2024 Precision oncology company Sentinal4D completes pre-seed funding round and launches to the public The Institute of Cancer Research
20-Dec-2024 NHS Scotland partner backs government calls for engagement in public consultation on medical device regulations InnoScot Health
20-Dec-2024 Pioneers in Pediatrics AccessWire
20-Dec-2024 121 Local & Regional EHR Vendors Across 53 Countries to Know: Showcasing Global Health IT Achievements With Insights From Black Book Research AccessWire
20-Dec-2024 Quantum Biopharma Diversifies Treasury With the Purchase of USD $1,000,000 of Bitcoin (BTC) and Other Cryptocurrencies and to Allow for Future Financings and Other Transactions in Cryptocurrency Newswire
20-Dec-2024 The Importance of Accurate Eligibility Verification for Providers 247 Medical Billing services
20-Dec-2024 Viromed Medical AG completes acquisition of pharmedix GmbH Viromed Medical AG
20-Dec-2024 Mentavi Health Offers Tips and Tools to Help Manage Stress During the Holiday Season AccessWire
20-Dec-2024 Accelerating and enhancing toxicology assessments Broughton
20-Dec-2024 Pedmarqsi® (anhydrous sodium thiosulfate) recommended by NICE for patients 1 month to 17 years of age in England and Wales for the prevention of cisplatin-induced hearing loss Norgine Pharmaceuticals Ltd
20-Dec-2024 Nxera Pharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference Nxera Pharma
20-Dec-2024 Epitopea and Genevant Sciences Announce Collaboration Agreement Epitopea
20-Dec-2024 Jean-Paul Kress to join Sanofi's Board of Directors Sanofi
20-Dec-2024 Pedmarqsi® (anhydrous sodium thiosulfate) recommended by NICE for patients 1 month to 17 years of age in England and Wales for the prevention of cisplatin-induced hearing loss Norgine Pharmaceuticals Ltd